rivastigmine has been researched along with Hip Fractures in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, BS; Ha, YC; Kim, S; Lee, JY; Shin, HW; Youn, YC | 1 |
| Anderson, G; Austin, PC; Gill, SS; Gruneir, A; Reimer, CL; Rochon, PA; Seitz, DP | 1 |
| Dawid-Milner, MS; Gormaz, I; Martin, I; Mendez, L; Ojea, T; Perez, A; Rojas, F; Sanchez-Siles, JM; Tamimi, F; Tamimi, I | 1 |
1 trial(s) available for rivastigmine and Hip Fractures
| Article | Year |
|---|---|
Rivastigmine patch reduces the incidence of postoperative delirium in older patients with cognitive impairment.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cognitive Dysfunction; Delirium; Female; Hip Fractures; Humans; Incidence; Male; Multivariate Analysis; Odds Ratio; Postoperative Complications; Prospective Studies; Risk Factors; Rivastigmine | 2017 |
2 other study(ies) available for rivastigmine and Hip Fractures
| Article | Year |
|---|---|
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Cholinesterase Inhibitors; Cohort Studies; Critical Care; Dementia; Donepezil; Female; Galantamine; Hip Fractures; Humans; Indans; Male; Outcome and Process Assessment, Health Care; Phenylcarbamates; Piperidines; Pneumonia; Postoperative Complications; Respiratory Insufficiency; Resuscitation; Risk; Rivastigmine | 2011 |
Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Case-Control Studies; Cholinesterase Inhibitors; Donepezil; Female; Hip Fractures; Humans; Indans; Male; Odds Ratio; Phenylcarbamates; Piperidines; Regression Analysis; Risk; Rivastigmine | 2012 |